FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2078752003> ?p ?o ?g. }

• W2078752003 endingPage "22" @default.
• W2078752003 startingPage "11" @default.
• W2078752003 abstract "The effects of 4-benzhydryloxy-1-[3-(1H-tetrazol-5-yl)-propyl]piperidine (HQL-79), a newly developed antiallergic drug, on various chemical mediators and on chemical mediator release were investigated. Orally administered HQL-79 strongly inhibited the histamine-induced skin reaction in rats, and histamine- and 5-hydroxytryptamine (5-HT)-induced bronchoconstriction in guinea pigs. HQL-79 inhibited antigen-induced release of leukotriene (LT) B4, LTC4, histamine and prostaglandin (PG) D2 from the chopped lung tissues of actively sensitized guinea pigs. On the other hand, release of PGE2, one of the bronchoprotective prostanoids, was significantly enhanced by HQL-79. In an in vivo experiment, chronic administration of HQL-79 clearly reduced PGD2 contents and enhanced PGE2 contents in the lungs of repeatedly antigen-exposed guinea pigs. In biochemical studies, HQL-79 inhibited mouse spleen PGD synthase in a concentration-dependent manner. None of the antiallergics such as epinastine, terfenadine, oxatomide and cetirizine inhibited the PGD synthase. HQL-79 did not affect PGE synthase in sheep vesicular gland microsomes. These results suggest that antiallergic and antiasthmatic effects of HQL-79 could be ascribed to antihistaminic- and anti-5-HT effects, chemical mediator release inhibition, PGE2-release enhancement and PGD synthase inhibition. It is considered, in particular, that the differential modulation of PGD2 and PGE2 production is a conspicuous pharmacological feature of HQL-79." @default.
• W2078752003 created "2016-06-24" @default.
• W2078752003 creator A5008798441 @default.
• W2078752003 creator A5030209507 @default.
• W2078752003 creator A5036226907 @default.
• W2078752003 creator A5038194793 @default.
• W2078752003 creator A5046834534 @default.
• W2078752003 creator A5055689662 @default.
• W2078752003 creator A5062342793 @default.
• W2078752003 creator A5064858996 @default.
• W2078752003 creator A5070557609 @default.
• W2078752003 creator A5087566652 @default.
• W2078752003 creator A5088660482 @default.
• W2078752003 date "1998-01-01" @default.
• W2078752003 modified "2023-09-27" @default.
• W2078752003 title "Pharmacological Studies on the Novel Antiallergic Drug HQL-79: II. Elucidation of Mechanisms for Antiallergic and Antiasthmatic Effects" @default.
• W2078752003 cites W1847502419 @default.
• W2078752003 cites W1965819980 @default.
• W2078752003 cites W1966866092 @default.
• W2078752003 cites W1966911529 @default.
• W2078752003 cites W1969849186 @default.
• W2078752003 cites W1973568930 @default.
• W2078752003 cites W1975002369 @default.
• W2078752003 cites W1977406435 @default.
• W2078752003 cites W1977899841 @default.
• W2078752003 cites W1986420435 @default.
• W2078752003 cites W1990174772 @default.
• W2078752003 cites W2004333960 @default.
• W2078752003 cites W2005654633 @default.
• W2078752003 cites W2015833775 @default.
• W2078752003 cites W2042143373 @default.
• W2078752003 cites W2077945404 @default.
• W2078752003 cites W2082468764 @default.
• W2078752003 cites W2094687957 @default.
• W2078752003 cites W2323764868 @default.
• W2078752003 cites W991595056 @default.
• W2078752003 doi "https://doi.org/10.1254/jjp.78.11" @default.
• W2078752003 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9804057" @default.
• W2078752003 hasPublicationYear "1998" @default.
• W2078752003 type Work @default.
• W2078752003 sameAs 2078752003 @default.
• W2078752003 citedByCount "48" @default.
• W2078752003 countsByYear W20787520032012 @default.
• W2078752003 countsByYear W20787520032013 @default.
• W2078752003 countsByYear W20787520032014 @default.
• W2078752003 countsByYear W20787520032017 @default.
• W2078752003 countsByYear W20787520032019 @default.
• W2078752003 countsByYear W20787520032020 @default.
• W2078752003 countsByYear W20787520032021 @default.
• W2078752003 crossrefType "journal-article" @default.
• W2078752003 hasAuthorship W2078752003A5008798441 @default.
• W2078752003 hasAuthorship W2078752003A5030209507 @default.
• W2078752003 hasAuthorship W2078752003A5036226907 @default.
• W2078752003 hasAuthorship W2078752003A5038194793 @default.
• W2078752003 hasAuthorship W2078752003A5046834534 @default.
• W2078752003 hasAuthorship W2078752003A5055689662 @default.
• W2078752003 hasAuthorship W2078752003A5062342793 @default.
• W2078752003 hasAuthorship W2078752003A5064858996 @default.
• W2078752003 hasAuthorship W2078752003A5070557609 @default.
• W2078752003 hasAuthorship W2078752003A5087566652 @default.
• W2078752003 hasAuthorship W2078752003A5088660482 @default.
• W2078752003 hasBestOaLocation W20787520031 @default.
• W2078752003 hasConcept C1122143 @default.
• W2078752003 hasConcept C185592680 @default.
• W2078752003 hasConcept C203014093 @default.
• W2078752003 hasConcept C2776042228 @default.
• W2078752003 hasConcept C2776452501 @default.
• W2078752003 hasConcept C2777361909 @default.
• W2078752003 hasConcept C2779543280 @default.
• W2078752003 hasConcept C2780571441 @default.
• W2078752003 hasConcept C2780664492 @default.
• W2078752003 hasConcept C55493867 @default.
• W2078752003 hasConcept C86803240 @default.
• W2078752003 hasConcept C98274493 @default.
• W2078752003 hasConceptScore W2078752003C1122143 @default.
• W2078752003 hasConceptScore W2078752003C185592680 @default.
• W2078752003 hasConceptScore W2078752003C203014093 @default.
• W2078752003 hasConceptScore W2078752003C2776042228 @default.
• W2078752003 hasConceptScore W2078752003C2776452501 @default.
• W2078752003 hasConceptScore W2078752003C2777361909 @default.
• W2078752003 hasConceptScore W2078752003C2779543280 @default.
• W2078752003 hasConceptScore W2078752003C2780571441 @default.
• W2078752003 hasConceptScore W2078752003C2780664492 @default.
• W2078752003 hasConceptScore W2078752003C55493867 @default.
• W2078752003 hasConceptScore W2078752003C86803240 @default.
• W2078752003 hasConceptScore W2078752003C98274493 @default.
• W2078752003 hasIssue "1" @default.
• W2078752003 hasLocation W20787520031 @default.
• W2078752003 hasLocation W20787520032 @default.
• W2078752003 hasOpenAccess W2078752003 @default.
• W2078752003 hasPrimaryLocation W20787520031 @default.
• W2078752003 hasRelatedWork W1510739691 @default.
• W2078752003 hasRelatedWork W1642315092 @default.
• W2078752003 hasRelatedWork W1984715043 @default.
• W2078752003 hasRelatedWork W1987152822 @default.
• W2078752003 hasRelatedWork W2009901024 @default.
• W2078752003 hasRelatedWork W2055027598 @default.
• W2078752003 hasRelatedWork W2064339899 @default.

• next